COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,878 Articles (22,568 medRxiv, 8,310 bioRxiv)

Most recent first Previous |  Page 2262: Articles 22611-22620  | Next

Drug repurposing screen identifies masitinib as a 3CLpro inhibitor that blocks replication of SARS-CoV-2 in vitro
Drayman, N., Jones, K. A., Azizi, S.-A., Froggatt, H. M., Tan, K., Ivanova Maltseva, N., Chen, S., Nicolaescu, V., Dvorkin, S., Furlong, K., Kathayat, R. S., Firpo, M. R., Mastrodomenico, V., Bruce, E. A., Schmidt, M. M., Jedrzejczak, R., Munoz-Alia, M. A., Schuster, B., Nair, V., Botten, J. W., Brooke, C. B., Baker, S. C., Mounce, B. C., Heaton, N. S., Dickinson, B. C., Jaochimiak, A., Randall, G., Tay, S.
10.1101/2020.08.31.274639 — Posted: 2020-09-01 Discussion: Onsite
Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India
Nayak, K., Gottimukkala, K., Kumar, S., Reddy, E. S., Edara, V. V., Kauffman, R., Floyd, K., Mantus, G., Savargaonkar, D., Goel, P. K., Arora, S., Rahi, M., Davis, C. W., Linderman, S., Wrammert, J., Suthar, M., Ahmed, R., Sharma, A., Murali-Krishna, K., Chandele, A.
10.1101/2020.08.31.276675 — Posted: 2020-09-01
Engineered Trimeric ACE2 Binds and Locks "Three-up" Spike Protein to Potently Inhibit SARS-CoVs and Mutants
Guo, L., Bi, W., Wang, X., Xu, W., Yan, R., Zhang, Y., Zhao, K., Li, Y., Zhang, M., Bao, X., Cai, X., Li, Y., Qu, D., Jiang, S., Xie, Y., Zhou, Q., Lu, L., Dang, B.
10.1101/2020.08.31.274704 — Posted: 2020-09-01
Convalescent Plasma for COVID-19: A multicenter, randomized clinical trial
Avendano-Sola, C., Ramos-Martinez, A., Munez-Rubio, E., Ruiz-Antoran, B., Malo de Molina, R., Torres, F., Fernandez-Cruz, A., Callejas-Diaz, A., Calderon, J., Payares-Herrera, C., Salcedo, I., Romera, I., Lora-Tamayo, J., Mancheno-Losa, M., Paciello, M. L., Villegas, C., Estrada, V., Saez-Serrano, I., Porras-Leal, M. L., Jarilla-Fernandez, M. d. C., Pano-Pardo, J. R., Moreno-Chulilla, J. A., Arrieta-Aldea, I., Bosch, A., Belhassen-Garcia, M., Lopez-Villar, O., Ramos-Garrido, A., Blanco, L., Madrigal, M. E., Contreras, E., Muniz-Diaz, E., Domingo-Morera, J. M., Casas-Flecha, I., Perez-Olmeda, M., Garcia-Perez, J., Alcami, J., Bueno, J. L., Duarte, R. F.
10.1101/2020.08.26.20182444 — Posted: 2020-09-01
The importance of saturating density dependence for predicting SARS-CoV-2 resurgence
Nightingale, E., Brady, O. J., Yakob, L.
10.1101/2020.08.28.20183921 — Posted: 2020-09-01
Risk factors for severe outcomes of COVID-19: a rapid review
Wingert, A., Pillay, J., Gates, M., Guitard, S., Rahman, S., Beck, A., Vandermeer, B., Hartling, L.
10.1101/2020.08.27.20183434 — Posted: 2020-09-01
Implementation and validation of a pooling strategy for a sustainable screening campaign for the presence of SARS-CoV-2.
Cesselli, D., Bulfoni, M., Marzinotto, S., Marcon, B., Cmet, S., Migotti, A., Cussigh, A. R., Martinella, R., Pipan, C., Beltrami, A. P., Curcio, F.
10.1101/2020.08.28.20174946 — Posted: 2020-09-01
A Comparison of Covid-19 Patient Characteristics Before versus After Partial Lockdown in Vietnam
Vo, H.-L., Nguyen, H. A. S., Nguyen, T. P. T., Nguyen, K. N., Vu, K.-D., Anh, V. D. T., Nguyen, T. T., Hoang, M. T., Nguyen, T. H. T., Vu, G. T., Le, H. T.
10.1101/2020.08.27.20183616 — Posted: 2020-09-01
Sex-based clinical and immunological differences in COVID-19
Li, K., Huang, B., Cai, Y., Wang, Z., Li, L., Wu, L., Zhu, M., Li, J., Wang, Z., Wu, M., Li, W., Wu, W., Zhang, L., Xia, X., Wang, S., Wang, Q.
10.1101/2020.08.29.20126201 — Posted: 2020-09-01
Social Determinants Associated with COVID-19 Mortality in the United States
Debopadhaya, S., Sprague, A. D., Mou, H., Benavides, T. L., Ahn, S. M., Reschke, C. A., Erickson, J. S., Bennett, K. P.
10.1101/2020.08.28.20183848 — Posted: 2020-09-01

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).